$0.00 $0.01 (0.0%)

12:00 AM EST on 01/01/01

NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: No stars

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

Current Price $0.00 Mkt Cap $0.00
Open $0.00 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 310,782
52-Wk Range $27.98 - $30.00 Avg. Daily Vol.

Caps

How do you think NASDAQ:NXTM will perform against the market?

Add Stock to CAPS Watchlist

All Players

137 Outperform
32 Underperform
 

All-Star Players

26 Outperform
7 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top NASDAQ:NXTM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

stocklade (55.53)
Submitted January 26, 2013

Great way of treating renal diseases, Can 't understand why they haven 't Done better. ? Doctor owned dialysis centers

mojo2007 (< 20)
Submitted March 22, 2008

If there's one thing I've learned, it's that when a stock is at its 52 week low, it's probably going to go lower before it goes higher. Don't try to find the bottom.

Recent Community Commentary

Read the most recent pitches from players about NXTM.

Recs

0
Member Avatar TMFEBCapital (77.29) Submitted: 5/3/2017 10:16:23 AM : Outperform Start Price: $28.91 NASDAQ:NXTM Score: -25.89

Rising prevelance of end stage kidney disease requiring dialysis is being driven by a larger population and a higher rate of diabetes, and other diseases that negatively impact kidney function. The market for dialysis is ripe for disruption, and at-home solutions offer an intriguing less-burdensome patient option. This company isn't growing by leaps and bounds, but solid high single digit to low double digit growth on the top line should finally translate into consistent profit from here on out -- and that profit should grow far more quickly than the top line.

Recs

1
Member Avatar stocklade (55.53) Submitted: 1/25/2013 11:59:19 PM : Outperform Start Price: $11.75 NASDAQ:NXTM Score: +49.72

Great way of treating renal diseases, Can 't understand why they haven 't Done better. ? Doctor owned dialysis centers

Recs

0
Member Avatar halley12 (39.21) Submitted: 10/9/2012 12:46:29 AM : Outperform Start Price: $12.86 NASDAQ:NXTM Score: +20.91

New technology.

Leaderboard

Find the members with the highest scoring picks in NXTM.

Score Leader

WALLSTREETSUCKS

WALLSTREETSUCKS (< 20) Score: +963.87

The Score Leader is the player with the highest score across all their picks in NXTM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WALLSTREETSUCKS < 20 5/11/2009 Outperform NS $2.30 +1,204.35% +240.48% +963.87 0 Comment
tfedorchuk 72.05 4/22/2009 7/2/2013 Outperform 1Y $2.28 +1,215.85% +264.27% +951.58 0 Comment
PoppaPickems 66.79 4/23/2009 Outperform NS $2.30 +1,204.35% +268.62% +935.73 0 Comment
BudFox24 39.30 5/26/2009 Outperform 3W $2.95 +916.95% +253.42% +663.53 0 Comment
hankin < 20 8/18/2008 Outperform 1Y $3.57 +740.34% +144.47% +595.87 0 Comment
AndreylikesMTL 84.09 2/11/2009 Outperform 5Y $3.40 +782.35% +276.37% +505.99 0 Comment
2st5 84.79 1/8/2009 Outperform NS $3.52 +752.27% +249.67% +502.60 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Rivermonster < 20 6/25/2008 Outperform 3W $4.17 +620.29% +140.89% +479.40 0 Comment
tomkom44 < 20 3/14/2008 Outperform NS $4.55 +559.34% +142.54% +416.80 0 Comment
coolMD 36.92 11/3/2008 Outperform 3Y $4.05 +640.74% +228.12% +412.62 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NXTM.